EGFR and non-small cell lung carcinoma: Compared with GEM, GEM-ZZQ also had less toxic effects on normal human epithelial cells and a similar growth inhibition effect on various NSCLC cell lines as well as superior synergistic effects with cisplatin in the low dose on EGFR-TKI osimertinib-resistant cell lines.